Abstract

IntroductionThe coronavirus disease 2019 (COVID-19) vaccine is available across various countries worldwide, with public-private partnerships ensuring all individuals are vaccinated through a phased approach. Irrespective of the geographical spread, several myths pertaining to the COVID-19 vaccine have stemmed, ultimately limiting the national administration of vaccines and rollouts. This study assessed the acceptance of the COVID-19 vaccine among the general public in Pakistan.MethodsA pre-validated questionnaire was administered from January 2021 to February 2021 to assess the public attitude and acceptance of the COVID-19 vaccine. Logistic regression analyses were run to identify factors associated with the acceptance among the population.ResultsA total of 936 responses were elicited, where 15% perceived their risk of being infected at 20-30% with an overall 70% agreeing to be vaccinated if recommended. Multivariate analysis identified higher acceptance in the male gender, healthcare workers, and students. Of all, 66% respondents chose healthcare workers and public officials, whereas 15.6% chose scientific literature, and 12.9% chose social media as the most reliable source of COVID-19 information.ConclusionGiven the relatively greater trust in healthcare providers for information regarding COVID-19, healthcare workers ought to be on the frontline for vaccine campaigns and public outreach efforts, with governmental efforts in addition to the promotion of scientific materials for population-level understanding.

Highlights

  • ObjectivesWith five vaccines (AstraZeneca, Sinopharm, CanSino, Sputnik V, and Gamaleya) approved for use in Pakistan as of June 29, 2021, along with the phased rollout approach of mass vaccination, this study aimed to assess the acceptance of the COVID-19 vaccine among the general public

  • The coronavirus disease 2019 (COVID-19) vaccine is available across various countries worldwide, with public-private partnerships ensuring all individuals are vaccinated through a phased approach

  • Our study shows that males, healthcare workers, and medical students are more likely to accept the vaccine, whereas the chances of immunizing the masses are higher if the vaccine is given free of cost

Read more

Summary

Objectives

With five vaccines (AstraZeneca, Sinopharm, CanSino, Sputnik V, and Gamaleya) approved for use in Pakistan as of June 29, 2021, along with the phased rollout approach of mass vaccination, this study aimed to assess the acceptance of the COVID-19 vaccine among the general public. This study aimed to inform medical communities about the causes of gaps in vaccine administration in LMIC, with relevant public health findings to ensure uniform vaccine rollouts

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call